KENOX PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Jul 2022)
What this means for you
This application is over — abandoned 11 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88168882
- Mark type
- Design + words
- Filed
- 25 Oct 2018
- Published for opposition
- 09 Apr 2019
- Abandoned
- 11 Jul 2022
- Attorney of record
- Y. Jae Kim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of deep vein thrombosis (DVT) and pulmonary embolisms, mental health conditions in the nature of bipolar disorder and schizophrenia, and diseases of the lungs, eye, and skin
Owner
- Kenox Pharmaceuticals Inc., South Plainfield, NJ, US
- Kenox Pharmaceuticals Inc., South Plainfield, NJ, US
Prosecution history
- 11 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2021 — SOU EXTENSION 5 GRANTED
- 06 Dec 2021 — SOU EXTENSION 5 FILED
- 13 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 08 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2021 — SOU EXTENSION 4 GRANTED
- 04 Jun 2021 — SOU EXTENSION 4 FILED
- 04 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2020 — SOU EXTENSION 3 GRANTED
- 04 Nov 2020 — SOU EXTENSION 3 FILED
- 04 Nov 2020 — SOU TEAS EXTENSION RECEIVED